Evidence map›Paper›PMID 18676889›Full record

ArticleAntimicrobial agents and chemotherapy2008

Novel insertion sequence- and transposon-mediated genetic rearrangements in genomic island SGI1 of Salmonella enterica serovar Kentucky.

Benoît Doublet, Karine Praud, Sophie Bertrand, Jean-Marc Collard, François-Xavier Weill, Axel Cloeckaert

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 78 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Genomic and Evolutionary Analysis ofFrontiers in cellular and infection microbiology · 2022
    Article
  5. Multilocus sequence typing of multidrug-resistant Salmonella strains circulating in poultry farms of Bangladesh.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2021
    Article
  6. Article
  7. Genomic Analysis of Ciprofloxacin-ResistantFrontiers in microbiology · 2021
    Article
  8. Article
  9. Ciprofloxacin-ResistantMicroorganisms · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. ISFrontiers in microbiology · 2019
    Article
  14. Article
  15. Identification and Characterization ofFrontiers in microbiology · 2019
    Article
  16. Article
  17. Article
  18. Characterization of Novel Integrons, InFrontiers in microbiology · 2017
    Article
  19. Article
  20. The risk of carriage ofVeterinary medicine and science · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Benoît DoubletCentre National de Référence des Salmonella, Laboratoire des Bactéries Pathogènes Entériques, Institut Pasteur, 28 Rue du Docteur Roux, 75724 Paris Cedex 15, France. Benoit.Doublet@tours.inra.fr
Karine Praud
Sophie Bertrand
Jean-Marc Collard
François-Xavier Weill
Axel Cloeckaert
Infectiologie Animale et Santé Publique · FRInstitut Scientifique de Santé Publique · BEInstitut Pasteur · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Salmonella genomic island 1 (SGI1) is an integrative mobilizable element that harbors a multidrug resistance (MDR) gene cluster. Since its identification in epidemic Salmonella enterica serovar Typhimurium DT104 strains, variant SGI1 MDR gene clusters conferring different MDR phenotypes have been identified in several S. enterica serovars and classified as SGI1-A to -O. A study was undertaken to characterize SGI1 from serovar Kentucky strains isolated from travelers returning from Africa. Several strains tested were found to contain the partially characterized variant SGI1-K, recently described in a serovar Kentucky strain isolated in Australia. This variant contained only one cassette array, aac(3)-Id-aadA7, and an adjacent mercury resistance module. Here, the uncharacterized part of SGI1-K was sequenced. Downstream of the mer module similar to that found in Tn21, a mosaic genetic structure was found, comprising (i) part of Tn1721 containing the tetracycline resistance genes tetR and tet(A); (ii) part of Tn5393 containing the streptomycin resistance genes strAB, IS1133, and a truncated tnpR gene; and (iii) a Tn3-like region containing the tnpR gene and the beta-lactamase bla(TEM-1) gene flanked by two IS26 elements in opposite orientations. The rightmost IS26 element was shown to be inserted into the S044 open reading frame of the SGI1 backbone. This variant MDR region was named SGI1-K1 according to the previously described variant SGI1-K. Other SGI1-K MDR regions due to different IS26 locations, inversion, and partial deletions were characterized and named SGI1-K2 to -K5. Two new SGI1 variants named SGI1-P1 and -P2 contained only the Tn3-like region comprising the beta-lactamase bla(TEM-1) gene flanked by the two IS26 elements inserted into the SGI1 backbone. Three other new variants harbored only one IS26 element inserted in place of the MDR region of SGI1 and were named SGI1-Q1 to -Q3. Thus, in serovar Kentucky, the SGI1 MDR region undergoes recombinational and insertional events of transposon and insertion sequences, resulting in a higher diversity of MDR gene clusters than previously reported and consequently a higher diversity of MDR phenotypes.

Indexed as

Gene RearrangementGenomic IslandsAfricaBase SequenceCloning, MolecularDNA, BacterialDNA PrimersDNA Transposable ElementsGenes, MDRGenetic VariationHumansMolecular Sequence DataPolymerase Chain ReactionSalmonella entericaSalmonella InfectionsDNA, BacterialDNA PrimersDNA Transposable Elements

Identifiers

PMID18676889
PMCPMC2565918
OpenAlexW2150860056

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.